date:Nov 01, 2012
illion on revenue of 699 million.
Nonetheless, Lars Frederiksen, Chr Hansens chief executive provided a cautious forecast for 2012/13, stating that the firm could experience weaker growth in the first quarter ad continued challenges in Europe resulting from the euro zone debt crisis. Frederiksen said that the firm expects to deliver organic growth of around 8-10%.
Frederiksen insisted that the firm remains committed to probiotics after being forced to write off 4 million from an immunity clin